deux
group
de
veaux
de
moi
furent
par
la
voie
intramusculair
en
utilis
une
souch
vivant
de
rotaviru
bovin
avec
de
dose
de
rappel
aux
jour
et
la
premi
e
immunis
un
premier
group
de
troi
veaux
fut
avec
le
viru
dan
une
eau
dart
rhuil
avec
radjuv
incomplet
de
freund
aif
alor
que
le
animaux
du
group
furent
avec
le
viru
avec
un
tampon
phosphat
salin
pb
troi
veaux
furent
avec
le
pb
dan
raif
le
de
rdpons
de
cellulair
et
de
anticorp
de
animaux
furent
une
sur
la
stimul
vitro
de
lymphocyt
du
sang
par
le
rotaviru
bovin
avait
penni
le
condit
optimal
pour
la
du
test
une
incub
de
h
de
cultur
une
de
x
cellul
par
cultur
en
utilis
le
milieu
rpmi
de
de
foetal
bovin
et
rutilis
de
viru
h
une
concentr
de
x
particul
viral
produis
un
effet
cytopathiqu
sur
de
cultur
cellulair
avant
rinactiv
une
stimul
lymphoblastiqu
fut
chez
le
veaux
avec
le
viru
et
iaif
le
et
troisidm
dose
vaccinal
le
indic
de
stimul
variant
de
ce
dernier
veaux
ont
aussi
de
titr
en
anticorp
neutralis
de
le
veaux
avec
le
viru
et
le
pb
ont
aussi
une
en
anticorp
avec
un
titr
moyen
de
san
manifest
toutefoi
une
stimul
lymphoblastiqu
le
veaux
nont
aucun
augment
de
immunitair
rotaviru
bovin
test
de
stimul
lymphoblastiqu
cellulair
anticorp
neutralis
vaccin
adjuv
introduct
rotaviru
consid
main
agent
incrimin
diarrhea
children
newborn
anim
calv
diarrhea
due
rotaviru
appear
mostli
first
wk
life
induct
activ
immun
local
intestin
system
follow
oral
vaccin
experiment
infect
calf
report
instanc
oral
vaccin
calv
challeng
h
vaccin
remain
normal
show
signific
neutral
antibodi
respons
intestin
serum
bachmann
et
al
detect
specif
antibodi
jejunum
fece
day
day
respect
follow
rotaviru
infect
similar
observ
also
report
van
zaan
et
al
detect
specif
fecal
antibodi
igm
iga
class
day
respect
rotaviru
infect
anoth
studi
show
inocul
attenu
bovin
rotaviru
either
oral
directli
isol
intestin
loop
induc
appear
rotaviru
antibodyproduc
cell
locat
mucosa
proxim
small
intestin
local
product
specif
immunoglobulin
mainli
iga
class
passiv
protect
calv
rotaviru
infect
may
obtain
immun
dam
last
trimest
pregnanc
adjuv
rotaviru
specif
antirotavir
antibodi
mainli
igg
present
colostrum
milk
vaccin
cow
shown
respons
passiv
protect
hand
cell
mediat
immun
cmi
consid
import
protect
recoveri
certain
viral
infect
lymphocyt
stimul
test
lst
blastic
transform
respons
mitogen
antigen
includ
infecti
agent
use
vitro
correl
cmi
anim
human
purpos
present
studi
report
standard
applic
lst
vitro
correl
cmi
bovin
follow
system
immun
adjuv
bovin
rotaviru
african
green
monkey
kidney
cell
bsci
propag
monolay
cm
plastic
cultur
flask
corn
glass
work
new
york
use
eagl
minimum
essenti
medium
earl
salt
lglutamin
emem
flow
laboratori
rockvil
maryland
supplement
heatinactiv
fetal
bovin
serum
fb
gibco
laboratori
chagrin
fall
ohio
iuml
penicillin
tgml
streptomycin
flow
laboratori
viru
product
infect
cell
maintain
emem
supplement
bovin
crystal
trypsin
sigma
chemic
compani
st
loui
missouri
ememt
antibiot
rotaviru
use
studi
plaquepurifi
neonat
calf
diarrhea
viru
ncdv
strain
virus
produc
previous
describ
use
anim
vaccin
lst
cell
exhibit
cytopath
effect
cpe
viru
harvest
osmot
shock
follow
trichlorofluoroethan
freon
dupont
canada
limit
maitland
ontario
extract
virus
purifi
isopycn
gradient
ultracentrifug
describ
fauvel
et
al
centrifug
h
fraction
rang
gml
viral
band
gml
locat
collect
dialyz
overnight
buffer
ph
viral
titer
determin
calcul
median
tissu
cultur
infect
dose
tcidso
per
ml
describ
threemonth
old
male
holsteinfreisian
calv
neglig
rotavir
serum
antibodi
titer
neutral
test
kept
isol
barn
control
temperatur
ventil
anim
allow
adapt
surround
wk
start
experi
optim
specif
lst
two
calv
inocul
intramuscularli
everi
wk
two
semitendin
semimembran
region
ml
mixtur
ml
per
site
contain
ml
live
purifi
rotaviru
suspens
x
emulsifi
ml
incomplet
viru
use
specif
antigen
lst
inactiv
method
previous
describ
bahnemann
briefli
ml
purifi
viral
suspens
titer
inactiv
gml
protein
content
determin
biorad
protein
assay
biorad
laboratori
richmond
california
mix
ml
pb
ml
bea
hydrobromid
sigma
chemic
compani
ph
previous
activ
naoh
n
h
mixtur
incub
h
thereaft
ml
cold
sodium
thiosulf
ad
stop
inactiv
reaction
inactiv
viral
suspens
dialyz
h
three
chang
cultur
medium
use
lst
without
fb
viral
antigen
check
residu
infect
cell
kept
small
aliquot
noninfect
cell
lysat
antigen
similarli
prepar
fraction
gml
use
control
prepar
check
presenc
endotoxin
content
limulu
lysat
method
llm
use
commerci
kit
pyrotest
difco
laboratori
detroit
michigan
peripher
blood
collect
weekli
day
first
vaccin
dose
jugular
venipunctur
place
tube
contain
ml
sodium
citrat
anticoagul
blood
mix
equal
volum
pb
contain
vv
sodium
citrat
pbscitrat
buffi
coat
cell
obtain
centrifug
room
temperatur
min
g
mononuclear
cell
obtain
place
ml
mixtur
buffi
coat
cell
dilut
autolog
plasma
ml
ficollpaqu
pharmacia
uppsala
sweden
densiti
gml
centrifug
g
min
cell
recov
interfac
wash
time
pbscitrat
resuspend
desir
concentr
cell
collect
viabil
trypan
blue
dye
exclus
method
smear
stain
wright
solut
show
cell
lymphocyt
optim
bovin
rotaviru
lst
isol
cell
resuspend
differ
concentr
x
cellsml
rpmi
medium
flow
laboratori
supplement
fb
mmol
lglutamin
flow
laboratori
antibiot
cell
cultur
medium
shown
free
endotoxin
use
test
llm
cell
suspens
ad
well
flatbottom
well
microtit
plate
flow
laboratori
quadrupl
well
receiv
either
viral
antigen
use
differ
concentr
cell
lysat
antigen
control
lymphocyt
cultur
incub
day
humidifi
atmospher
stimul
cell
concanavalin
con
difco
laboratori
use
optim
concentr
alway
done
cell
sampl
use
concentr
x
day
incub
test
lymphocyt
cultur
puls
tritiat
thymidin
sp
act
new
england
nuclear
boston
massachusett
dilut
cultur
medium
without
fb
h
harvest
onto
filter
paper
disk
semiautom
multipl
cell
harvest
flow
laboratori
dri
filter
paper
disk
transfer
ml
vial
solubil
ml
aquasol
new
england
nuclear
scintil
fluid
min
vial
count
min
scintil
spectromet
model
ls
beckman
instrument
inc
palo
alto
california
data
express
count
per
minut
cpm
calcul
stimul
index
si
repres
ratio
cpm
incorpor
viru
contain
cultur
cpm
incorpor
control
cultur
lst
signific
si
presenc
specif
neutral
antibodi
carri
sera
obtain
calv
vaccin
day
day
first
vaccin
inocul
test
sera
inactiv
min
serial
dilut
start
serum
ememt
mix
equal
volum
ml
rotaviru
incub
h
residu
infect
test
quadrupl
use
confluent
cell
well
microtit
plate
volum
serumviru
mixtur
place
well
incub
min
allow
inoculum
remov
ememt
ad
well
plate
incub
final
read
made
fourth
day
cpe
complet
viru
control
cultur
antibodi
titer
serum
express
highest
reciproc
dilut
neutral
viru
paramet
number
cell
per
cultur
incub
time
viral
concentr
analys
data
collect
wk
third
vaccin
inocul
calv
tabl
show
concentr
mononuclear
tabl
base
result
condit
use
subsequ
bovin
rotaviru
lst
includ
use
x
lymphocyt
per
well
x
inactiv
viral
particl
per
well
incub
period
day
kinet
specif
neutral
antibodi
serum
group
calv
present
fig
signific
immun
respons
obtain
earli
day
first
vaccin
inocul
two
group
immun
viru
anamnest
respons
observ
group
booster
inocul
given
day
postprimari
immun
ppi
group
vaccin
rotavir
waterinoil
emuls
show
mean
neutral
antibodi
titer
day
follow
ppi
group
vaccin
aqueou
rotavir
suspens
demonstr
intermedi
respons
reach
mean
antibodi
titer
signific
differ
p
student
ttest
antibodi
titer
two
rotavir
vaccin
group
observ
day
ppi
control
group
inocul
emuls
without
rotaviru
antibodi
titer
remain
minim
level
throughout
experi
figur
repres
kinet
peripher
blood
lymphocyt
stimul
vitro
bovin
rotaviru
neither
calv
control
group
fig
vaccin
aqueou
rotavir
suspens
fig
show
specif
lymphocyt
stimul
experi
vaccin
calv
rotaviru
emulsifi
ifa
result
specif
lymphocyt
activ
signific
si
vari
fig
also
show
two
peak
stimul
second
third
vaccin
inocul
lst
import
assay
evalu
immunolog
compet
anim
specif
immun
respons
differ
antigen
present
paper
lst
use
investig
cmi
respons
follow
intramuscular
vaccin
calv
rotaviru
standard
lst
bovin
rotaviru
differ
paramet
analys
optim
result
obtain
day
incub
x
lymphocyt
per
cultur
stimul
x
inactiv
viral
particl
lower
lymphocyt
specif
activ
determin
si
valu
day
cell
cultur
incub
probabl
due
diminut
cell
nutrient
result
mortal
cell
shorter
time
antigen
recognit
lymphocyt
respect
howev
possibl
presenc
suppress
cell
molecul
prostaglandin
cell
cultur
might
also
explain
lower
lymphocyt
activ
good
correl
also
obtain
si
valu
increas
number
cell
cultur
enhanc
probabl
contact
sensit
lymphocyt
antigen
ratio
viral
particl
mononuclear
cell
gave
best
result
studi
howev
one
experi
higher
ratio
viral
particl
cell
viral
particl
vs
cell
per
cultur
tabl
contribut
signific
augment
si
use
inactiv
viru
particl
specif
antigen
lst
chosen
instead
live
viru
sinc
report
human
rotavirus
may
infect
leukocyt
mitogen
stimul
potenti
abrog
lymphocyt
metabol
cell
mortal
import
fluctuat
control
cell
cultur
cpm
background
observ
among
individu
calv
also
calv
timecours
studi
data
shown
inde
mean
cpm
control
cell
cultur
vari
calv
similar
result
report
author
bovin
stimul
cell
con
primarili
mitogen
lymphocyt
mani
speci
includ
bovin
perform
check
viabil
function
activ
isol
cell
vaccin
calv
ifa
adjuv
bovin
rotaviru
induc
diphas
specif
lymphocyt
transform
previous
describ
bovin
even
singl
vaccin
inocul
furthermor
specif
vitro
lymphocyt
stimul
coincid
maxim
antibodi
titer
serum
calv
need
one
immun
correl
secondari
immun
respons
obtain
booster
vaccin
inocul
demonstr
studi
bovin
speci
use
ifa
adjuv
satisfactori
induc
signific
humor
immun
respons
follow
system
immun
bovin
rotaviru
increas
antibodi
format
gener
follow
inocul
antigen
incorpor
waterinoil
emuls
recogn
associ
antigendepot
effect
mean
greater
persist
antigen
vivo
thu
extend
period
antigen
stimul
attract
immunocompet
cell
area
inject
import
cmi
defens
role
demonstr
viral
infect
rotaviru
infect
demonstr
optim
cmi
measur
lst
splenic
lymphocyt
correl
end
viru
replic
intestin
follow
termin
diarrhea
young
infect
mice
anoth
report
show
delayedtyp
hypersensit
dth
elicit
subcutan
inocul
murin
rotaviru
observ
neonat
old
adult
old
mice
respect
day
follow
rotaviru
infect
oral
dth
respons
howev
seen
neonat
mice
infect
day
age
anoth
studi
report
abil
simian
rotavirusstimul
human
peripher
blood
leukocyt
produc
interferon
cytokin
stimul
kill
vitro
rotavirusinfect
cell
second
set
leukocyt
describ
natur
killer
cell
report
studi
immun
calv
adjuv
bovin
rotaviru
induc
vitro
specif
prolif
activ
peripher
blood
lymphocyt
howev
role
lymphocyt
sensit
bovin
rotaviru
remain
determin
